{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T11:12:37Z","timestamp":1788779557785,"version":"build-2803163510"},"reference-count":116,"publisher":"MDPI AG","issue":"20","license":[{"start":{"date-parts":[[2023,10,23]],"date-time":"2023-10-23T00:00:00Z","timestamp":1698019200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Celiac disease (CD) presents a complex interplay of both innate and adaptive immune responses that drive a variety of pathological manifestations. Recent studies highlight the role of immune-mediated pathogenesis, pinpointing the involvement of antibodies against tissue transglutaminases (TG2, TG3, TG6), specific HLA molecules (DQ2\/8), and the regulatory role of interleukin-15, among other cellular and molecular pathways. These aspects illuminate the systemic nature of CD, reflecting its wide-reaching impact that extends beyond gastrointestinal symptoms to affect other physiological systems and giving rise to a range of pathological landscapes, including refractory CD (RCD) and, in severe cases, enteropathy-associated T cell lymphoma. The existing primary therapeutic strategy, a gluten-free diet (GFD), poses significant challenges, such as low adherence rates, necessitating alternative treatments. Emerging therapies target various stages of the disease pathology, from preventing immunogenic gluten peptide absorption to enhancing intestinal epithelial integrity and modulating the immune response, heralding potential breakthroughs in CD management. As the understanding of CD deepens, novel therapeutic avenues are emerging, paving the way for more effective and sophisticated treatment strategies with the aim of enhancing the quality of life of CD patients. This review aims to delineate the immunopathology of CD and exploring its implications on other systems, its complications and the development of novel treatments.<\/jats:p>","DOI":"10.3390\/ijms242015482","type":"journal-article","created":{"date-parts":[[2023,10,23]],"date-time":"2023-10-23T10:32:24Z","timestamp":1698057144000},"page":"15482","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Unraveling the Immunopathological Landscape of Celiac Disease: A Comprehensive Review"],"prefix":"10.3390","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0412-1729","authenticated-orcid":false,"given":"Yonatan Shneor","family":"Patt","sequence":"first","affiliation":[{"name":"Department of Internal Medicine B, Sheba Medical Center, Ramat Gan 52621, Israel"},{"name":"Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv 69978, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1513-7280","authenticated-orcid":false,"given":"Adi","family":"Lahat","sequence":"additional","affiliation":[{"name":"Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv 69978, Israel"},{"name":"Department of Gastroenterology, Sheba Medical Center, Ramat Gan 52621, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0075-5895","authenticated-orcid":false,"given":"Paula","family":"David","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine B, Sheba Medical Center, Ramat Gan 52621, Israel"},{"name":"Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv 69978, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Patt","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine B, Sheba Medical Center, Ramat Gan 52621, Israel"},{"name":"The Adelson School of Medicine, Ariel University, Ariel 40700, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-1662-6101","authenticated-orcid":false,"given":"Rowand","family":"Eyade","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine B, Sheba Medical Center, Ramat Gan 52621, Israel"},{"name":"Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv 69978, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3905-3313","authenticated-orcid":false,"given":"Kassem","family":"Sharif","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine B, Sheba Medical Center, Ramat Gan 52621, Israel"},{"name":"Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv 69978, Israel"},{"name":"Department of Gastroenterology, Sheba Medical Center, Ramat Gan 52621, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,10,23]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1136\/gutjnl-2011-301346","article-title":"The Oslo definitions for coeliac disease and related terms","volume":"62","author":"Ludvigsson","year":"2013","journal-title":"Gut"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"53","DOI":"10.5409\/wjcp.v10.i4.53","article-title":"Celiac disease in children: A review of the literature","volume":"10","author":"Sahin","year":"2021","journal-title":"World J. Clin. Pediatr."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Vilppula, A., Kaukinen, K., Luostarinen, L., Krekel\u00e4, I., Patrikainen, H., Valve, R., M\u00e4ki, M., and Collin, P. (2009). Increasing prevalence and high incidence of celiac disease in elderly people: A population-based study. BMC Gastroenterol., 9.","DOI":"10.1186\/1471-230X-9-49"},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Caio, G., Volta, U., Sapone, A., Leffler, D.A., De Giorgio, R., Catassi, C., and Fasano, A. (2019). Celiac disease: A comprehensive current review. BMC Med., 17.","DOI":"10.1186\/s12916-019-1380-z"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1136\/gutjnl-2021-326257","article-title":"Immunopathogenesis and environmental triggers in coeliac disease","volume":"71","author":"Levescot","year":"2022","journal-title":"Gut"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"154","DOI":"10.3748\/wjg.v28.i1.154","article-title":"Current guidelines for the management of celiac disease: A systematic review with comparative analysis","volume":"28","author":"Raiteri","year":"2022","journal-title":"World J. Gastroenterol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.amjmed.2010.02.019","article-title":"Celiac disease diagnosis: Simple rules are better than complicated algorithms","volume":"123","author":"Catassi","year":"2010","journal-title":"Am. J. Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.fm.2006.07.004","article-title":"Chemistry of gluten proteins","volume":"24","author":"Wieser","year":"2007","journal-title":"Food Microbiol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/jgh.13703","article-title":"What is gluten?","volume":"32","author":"Biesiekierski","year":"2017","journal-title":"J. Gastroenterol. Hepatol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1006\/smim.2001.0310","article-title":"Oral tolerance","volume":"13","author":"Garside","year":"2001","journal-title":"Semin. Immunol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1016\/j.pcl.2015.07.013","article-title":"Mechanisms of Oral Tolerance","volume":"62","author":"Commins","year":"2015","journal-title":"Pediatr. Clin. North Am."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"h4347","DOI":"10.1136\/bmj.h4347","article-title":"Celiac disease and non-celiac gluten sensitivity","volume":"351","author":"Lebwohl","year":"2015","journal-title":"BMJ"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1749-6632.2012.06538.x","article-title":"Zonulin, regulation of tight junctions, and autoimmune diseases","volume":"1258","author":"Fasano","year":"2012","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.humimm.2006.03.011","article-title":"Celiac disease\u2014Sandwiched between innate and adaptive immunity","volume":"67","author":"Stepniak","year":"2006","journal-title":"Hum. Immunol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.4049\/jimmunol.180.3.1592","article-title":"Direct Action of Type I IFN on NK Cells Is Required for Their Activation in Response to Vaccinia Viral Infection In Vivo","volume":"180","author":"Martinez","year":"2008","journal-title":"J. Immunol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1007\/s00281-012-0316-x","article-title":"Intraepithelial lymphocytes in celiac disease immunopathology","volume":"34","author":"Abadie","year":"2012","journal-title":"Semin. Immunopathol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1053\/j.gastro.2006.12.025","article-title":"Inhibition of TGF-beta signaling by IL-15: A new role for IL-15 in the loss of immune homeostasis in celiac disease","volume":"132","author":"Benahmed","year":"2007","journal-title":"Gastroenterology"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"6763","DOI":"10.4049\/jimmunol.0801792","article-title":"IL-15 renders conventional lymphocytes resistant to suppressive functions of regulatory T cells through activation of the phosphatidylinositol 3-kinase pathway","volume":"182","author":"Ahmed","year":"2009","journal-title":"J. Immunol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1053\/j.gastro.2020.04.018","article-title":"Evidence That Pathogenic Transglutaminase 2 in Celiac Disease Derives From Enterocytes","volume":"159","author":"Iversen","year":"2020","journal-title":"Gastroenterology"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1038\/nm0698-713","article-title":"Tissue transglutaminase selectively modifies gliadin peptides that are recognized by gut-derived T cells in celiac disease","volume":"4","author":"Molberg","year":"1998","journal-title":"Nat. Med."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.4049\/jimmunol.173.3.1757","article-title":"Antigen presentation to celiac lesion-derived T cells of a 33-mer gliadin peptide naturally formed by gastrointestinal digestion","volume":"173","author":"Qiao","year":"2004","journal-title":"J. Immunol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1177\/2050640618765506","article-title":"The distribution of HLA DQ2 and DQ8 haplotypes and their association with health indicators in a general Danish population","volume":"6","author":"Thuesen","year":"2018","journal-title":"United Eur. Gastroenterol. J."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1136\/gut.24.6.532","article-title":"HLA-DR phenotypes in Spanish coeliac children: Their contribution to the understanding of the genetics of the disease","volume":"24","author":"Mearin","year":"1983","journal-title":"Gut"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1038\/mi.2010.36","article-title":"HLA-DQ2-restricted gluten-reactive T cells produce IL-21 but not IL-17 or IL-22","volume":"3","author":"Bodd","year":"2010","journal-title":"Mucosal Immunol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"137","DOI":"10.3389\/fmed.2017.00137","article-title":"New Insights into the Pathogenesis of Celiac Disease","volume":"4","author":"Magris","year":"2017","journal-title":"Front. Med."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1053\/j.gastro.2015.05.013","article-title":"Distinct and Synergistic Contributions of Epithelial Stress and Adaptive Immunity to Functions of Intraepithelial Killer Cells and Active Celiac Disease","volume":"149","author":"Setty","year":"2015","journal-title":"Gastroenterology"},{"key":"ref_27","unstructured":"Eagar, T.N., and Miller, S.D. (2023). Clinical Immunology: Principles and Practice, Elsevier. [6th ed.]."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/s00281-012-0305-0","article-title":"Role of Transglutaminase 2 in Celiac Disease Pathogenesis","volume":"34","author":"DiRaimondo","year":"2012","journal-title":"Semin. Immunopathol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1038\/nm0797-797","article-title":"Identification of tissue transglutaminase as the autoantigen of celiac disease","volume":"3","author":"Dieterich","year":"1997","journal-title":"Nat. Med."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/bs.acc.2014.12.006","article-title":"Overview of Biomarkers for Diagnosis and Monitoring of Celiac Disease","volume":"68","author":"Brusca","year":"2015","journal-title":"Adv. Clin. Chem."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1097\/MCG.0000000000000105","article-title":"Titers of anti-tissue transglutaminase antibody correlate well with severity of villous abnormalities in celiac disease","volume":"49","author":"Singh","year":"2015","journal-title":"J. Clin. Gastroenterol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.cca.2022.01.022","article-title":"Pathophysiology and immunogenetics of celiac disease","volume":"528","author":"Aboulaghras","year":"2022","journal-title":"Clin. Chim. Acta"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"17607","DOI":"10.1074\/jbc.M310198200","article-title":"Molecular characterization of covalent complexes between tissue transglutaminase and gliadin peptides","volume":"279","author":"Fleckenstein","year":"2004","journal-title":"J. Biol. Chem."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.bpg.2015.04.001","article-title":"T-cell and B-cell immunity in celiac disease","volume":"29","author":"Sollid","year":"2015","journal-title":"Best Pract. Res. Clin. Gastroenterol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.bpg.2005.02.001","article-title":"Refractory coeliac disease","volume":"19","author":"Daum","year":"2005","journal-title":"Best Pract. Res. Clin. Gastroenterol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1046\/j.1365-2559.2000.00926.x","article-title":"Distinction between coeliac disease and refractory sprue: A simple immunohistochemical method","volume":"37","author":"Cellier","year":"2000","journal-title":"Histopathology"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1007\/s00281-012-0322-z","article-title":"Refractory celiac disease: From bench to bedside","volume":"34","author":"Malamut","year":"2012","journal-title":"Semin. Immunopathol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1172\/JCI41344","article-title":"IL-15 triggers an antiapoptotic pathway in human intraepithelial lymphocytes that is a potential new target in celiac disease\u2013associated inflammation and lymphomagenesis","volume":"120","author":"Malamut","year":"2010","journal-title":"J. Clin. Investig."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1053\/j.gastro.2008.09.069","article-title":"Presentation and Long-Term Follow-up of Refractory Celiac Disease: Comparison of Type I with Type II","volume":"136","author":"Malamut","year":"2009","journal-title":"Gastroenterology"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1084\/jem.20060028","article-title":"Reprogramming of CTLs into natural killer\u2013like cells in celiac disease","volume":"203","author":"Meresse","year":"2006","journal-title":"J. Exp. Med."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1136\/gut.2009.195131","article-title":"Classification and management of refractory coeliac disease","volume":"59","author":"Murray","year":"2010","journal-title":"Gut"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1136\/gut.2009.186007","article-title":"Continual monitoring of intraepithelial lymphocyte immunophenotype and clonality is more important than snapshot analysis in the surveillance of refractory coeliac disease","volume":"59","author":"Liu","year":"2010","journal-title":"Gut"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1136\/gutjnl-2020-322935","article-title":"Oncogenetic landscape of lymphomagenesis in coeliac disease","volume":"71","author":"Cording","year":"2021","journal-title":"Gut"},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Durazzo, M., Ferro, A., Brascugli, I., Mattivi, S., Fagoonee, S., and Pellicano, R. (2022). Extra-Intestinal Manifestations of Celiac Disease: What Should We Know in 2022?. J. Clin. Med., 11.","DOI":"10.3390\/jcm11010258"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"27","DOI":"10.4291\/wjgp.v8.i2.27","article-title":"Celiac disease: From pathophysiology to treatment","volume":"8","author":"Parzanese","year":"2017","journal-title":"World J. Gastrointest. Pathophysiol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1016\/j.amjmed.2017.05.027","article-title":"Delay in Diagnosis of Celiac Disease in Patients Without Gastrointestinal Complaints","volume":"130","author":"Paez","year":"2017","journal-title":"Am. J. Med."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1007\/s00198-008-0624-0","article-title":"Bone in celiac disease","volume":"19","author":"Bianchi","year":"2008","journal-title":"Osteoporos. Int."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1080\/07853890.2016.1222450","article-title":"Dermatitis herpetiformis: A cutaneous manifestation of coeliac disease","volume":"49","author":"Collin","year":"2016","journal-title":"Ann. Med."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1097\/00004836-199002000-00010","article-title":"Obstetric and gynecological problems in women with untreated celiac sprue","volume":"12","author":"Molteni","year":"1990","journal-title":"J. Clin. Gastroenterol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"e001594","DOI":"10.1161\/JAHA.112.001594","article-title":"Risk of idiopathic dilated cardiomyopathy in 29 000 patients with celiac disease","volume":"1","author":"Emilsson","year":"2012","journal-title":"J. Am. Heart Assoc."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"8472","DOI":"10.3748\/wjg.v22.i38.8472","article-title":"Endocrine manifestations in celiac disease","volume":"22","author":"Freeman","year":"2016","journal-title":"World J. Gastroenterol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1046\/j.0305-1846.2000.00292.x","article-title":"The neurology and neuropathology of coeliac disease","volume":"26","author":"Wills","year":"2000","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"41","DOI":"10.4103\/0019-5154.198031","article-title":"Psoriasis and Risk of Celiac Disease: A Systematic Review and Meta-analysis","volume":"62","author":"Ungprasert","year":"2017","journal-title":"Indian J. Dermatol."},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Persechino, F., Galli, G., Persechino, S., Valitutti, F., Zenzeri, L., Mauro, A., Corleto, V.D., Parisi, P., Ziparo, C., and Evangelisti, M. (2021). Skin Manifestations and Coeliac Disease in Paediatric Population. Nutrients, 13.","DOI":"10.3390\/nu13103611"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/nrgastro.2015.131","article-title":"Extraintestinal manifestations of coeliac disease","volume":"12","author":"Leffler","year":"2015","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1111\/j.1468-3083.2009.03188.x","article-title":"Guidelines for the diagnosis and treatment of dermatitis herpetiformis","volume":"23","author":"Caproni","year":"2009","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1084\/jem.20011299","article-title":"Epidermal Transglutaminase (TGase 3) Is the Autoantigen of Dermatitis Herpetiformis","volume":"195","author":"Merkl","year":"2002","journal-title":"J. Exp. Med."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1111\/exd.13449","article-title":"Transglutaminases in autoimmune and inherited skin diseases: The phenomena of epitope spreading and functional compensation","volume":"27","author":"Mayer","year":"2018","journal-title":"Exp. Dermatol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"779","DOI":"10.3389\/fimmu.2018.00779","article-title":"Humoral epitope spreading in autoimmune bullous diseases","volume":"9","author":"Didona","year":"2018","journal-title":"Front. Immunol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.3389\/fimmu.2019.01290","article-title":"Dermatitis Herpetiformis: Novel Perspectives","volume":"10","author":"Antiga","year":"2019","journal-title":"Front. Immunol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0190-9622(83)70132-5","article-title":"Renal involvement and circulating immune complexes in dermatitis herpetiformis","volume":"9","author":"Reunala","year":"1983","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.1038\/sj.jid.5700929","article-title":"Serum IL-8 in Patients with Dermatitis Herpetiformis is Produced in Response to Dietary Gluten","volume":"127","author":"Hall","year":"2007","journal-title":"J. Investig. Dermatol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1046\/j.1365-2133.2002.05004.x","article-title":"Neutrophil CD11b, L-selectin and Fc IgA receptors in patients with dermatitis herpetiformis","volume":"147","author":"Smith","year":"2002","journal-title":"Br. J. Dermatol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1038\/sj.jid.5700277","article-title":"Cutaneous Endothelial Cell Activation in Normal Skin of Patients with Dermatitis Herpetiformis Associated with Increased Serum Levels of IL-8, sE-Selectin, and TNF-\u03b1","volume":"126","author":"Hall","year":"2006","journal-title":"Investig. Dermatol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"9690","DOI":"10.1038\/s41598-018-28070-0","article-title":"Granzyme B is elevated in autoimmune blistering diseases and cleaves key anchoring proteins of the dermal-epidermal junction","volume":"8","author":"Russo","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1093\/brain\/89.4.683","article-title":"Neurological Disorders Associated with Adult Celiac Disease","volume":"89","author":"Cooke","year":"1966","journal-title":"Brain"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"2678","DOI":"10.1016\/j.cgh.2019.03.014","article-title":"Neurologic Deficits in Patients with Newly Diagnosed Celiac Disease Are Frequent and Linked With Autoimmunity to Transglutaminase 6","volume":"17","author":"Hadjivassiliou","year":"2019","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"Rouvroye, M.D., Zis, P., Van Dam, A.-M., Rozemuller, A.J.M., Bouma, G., and Hadjivassiliou, M. (2020). The Neuropathology of Gluten-Related Neurological Disorders: A Systematic Review. Nutrients, 12.","DOI":"10.3390\/nu12030822"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"291045","DOI":"10.3389\/fnins.2017.00498","article-title":"Neurophysiology of the \u2018celiac brain\u2019: Disentangling gut-brain connections","volume":"11","author":"Pennisi","year":"2017","journal-title":"Front. Neurosci."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1053\/j.gastro.2007.04.070","article-title":"Sera of patients with celiac disease and neurologic disorders evoke a mitochondrial-dependent apoptosis in vitro","volume":"133","author":"Cervio","year":"2007","journal-title":"Gastroenterology"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s13223-021-00557-y","article-title":"Anti-ganglioside antibodies and celiac disease","volume":"17","author":"Granito","year":"2021","journal-title":"Allergy Asthma Clin. Immunol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/s41423-020-0388-9","article-title":"Physiology of gangliosides and the role of antiganglioside antibodies in human diseases","volume":"17","author":"Cutillo","year":"2020","journal-title":"Cell. Mol. Immunol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1002\/ana.21450","article-title":"Autoantibodies in gluten ataxia recognize a novel neuronal transglutaminase","volume":"64","author":"Hadjivassiliou","year":"2008","journal-title":"Ann. Neurol."},{"key":"ref_74","doi-asserted-by":"crossref","unstructured":"Giuffr\u00e8, M., Gazzin, S., Zoratti, C., Llido, J.P., Lanza, G., Tiribelli, C., and Moretti, R. (2022). Celiac Disease and Neurological Manifestations: From Gluten to Neuroinflammation. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms232415564"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.conb.2003.10.014","article-title":"The role of the thalamus in motor control","volume":"13","author":"Sommer","year":"2003","journal-title":"Curr. Opin. Neurobiol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1746-1596-6-14","article-title":"Selective loss of Purkinje cells in a patient with anti-gliadin-antibody-positive autoimmune cerebellar ataxia","volume":"6","author":"Nanri","year":"2011","journal-title":"Diagn. Pathol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"16163","DOI":"10.1038\/s41598-017-16342-0","article-title":"Endothelial cell-surface tissue transglutaminase inhibits neutrophil adhesion by binding and releasing nitric oxide","volume":"7","author":"Lai","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_78","doi-asserted-by":"crossref","unstructured":"Hadjivassiliou, M., Gr\u00fcnewald, R., Sanders, D.S., Zis, P., Croall, I., Shanmugarajah, P.D., Sarrigiannis, P.G., Trott, N., Wild, G., and Hoggard, N. (2018). The Significance of Low Titre Antigliadin Antibodies in the Diagnosis of Gluten Ataxia. Nutrients, 10.","DOI":"10.3390\/nu10101444"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/S1590-8658(01)80014-1","article-title":"Anti tissue transglutaminase antibodies as predictors of silent coeliac disease in patients with hypertransaminasaemia of unknown origin","volume":"33","author":"Volta","year":"2001","journal-title":"Dig. Liver Dis."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S1590-8658(02)80053-6","article-title":"Coeliac disease and secondary autoimmunity","volume":"34","author":"Schuppan","year":"2002","journal-title":"Dig. Liver Dis."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1111\/j.1365-2249.2004.02541.x","article-title":"Anti-actin IgA antibodies in severe coeliac disease","volume":"137","author":"Granito","year":"2004","journal-title":"Clin. Exp. Immunol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.coi.2011.08.006","article-title":"Celiac disease and transglutaminase 2: A model for posttranslational modification of antigens and HLA association in the pathogenesis of autoimmune disorders","volume":"23","author":"Sollid","year":"2011","journal-title":"Curr. Opin. Immunol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"9374","DOI":"10.1073\/pnas.142284899","article-title":"Restricted islet-cell reactive T cell repertoire of early pancreatic islet infiltrates in NOD mice","volume":"99","author":"Baker","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_84","first-page":"229","article-title":"HLA DQ2\/DQ8 haplotypes and anti-transglutaminase antibodies as celiac disease markers in a pediatric population with type 1 diabetes mellitus","volume":"66","author":"Oliveira","year":"2022","journal-title":"Arch. Endocrinol. Metab."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/S1590-8658(00)80354-0","article-title":"Prevalence of silent coeliac disease in atopics","volume":"32","author":"Zauli","year":"2000","journal-title":"Dig. Liver Dis."},{"key":"ref_86","first-page":"e26243","article-title":"Celiac Disease and Autoimmune Thyroid Disease: The Two Peas in a Pod","volume":"14","author":"Ashok","year":"2022","journal-title":"Cureus"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1530\/eje.0.1300137","article-title":"Autoimmune thyroid disorders and coeliac disease","volume":"130","author":"Collin","year":"1994","journal-title":"Eur. J. Endocrinol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1159\/000048840","article-title":"Coeliac disease in patients with autoimmune thyroiditis","volume":"64","author":"Volta","year":"2001","journal-title":"Digestion"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.1111\/j.1572-0241.2002.06031.x","article-title":"Celiac disease in autoimmune cholestatic liver disorders","volume":"97","author":"Volta","year":"2002","journal-title":"Am. J. Gastroenterol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1007\/s10875-008-9200-9","article-title":"Elevated serum anti-Saccharomyces cerevisiae, anti-I2 and anti-OmpW antibody levels in patients with suspicion of celiac disease","volume":"28","author":"Ashorn","year":"2008","journal-title":"J. Clin. Immunol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1111\/j.1365-2036.2005.02417.x","article-title":"Anti-Saccharomyces cerevisiae and perinuclear anti-neutrophil cytoplasmic antibodies in coeliac disease before and after gluten-free diet","volume":"21","author":"Granito","year":"2005","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_92","first-page":"296","article-title":"Anti-saccharomyces cerevisiae antibodies (ASCA) in coeliac disease","volume":"55","author":"Granito","year":"2006","journal-title":"Gut"},{"key":"ref_93","doi-asserted-by":"crossref","unstructured":"Machado, M.V. (2023). New Developments in Celiac Disease Treatment. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24020945"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/j.1365-2036.2009.04053.x","article-title":"Systematic review: Adherence to a gluten-free diet in adult patients with coeliac disease","volume":"30","author":"Hall","year":"2009","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_95","doi-asserted-by":"crossref","unstructured":"Hollon, J.R., Cureton, P.A., Martin, M.L., Puppa, E.L.L., and Fasano, A. (2013). Trace gluten contamination may play a role in mucosal and clinical recovery in a subgroup of diet-adherent non-responsive celiac disease patients. BMC Gastroenterol., 13.","DOI":"10.1186\/1471-230X-13-40"},{"key":"ref_96","first-page":"A5307","article-title":"Epidemiologic and therapeutic aspects of refractory coeliac disease\u2014A systematic review","volume":"63","author":"Rowinski","year":"2016","journal-title":"Dan. Med. J."},{"key":"ref_97","first-page":"181","article-title":"Current and emerging therapies for coeliac disease","volume":"18","author":"Caminero","year":"2020","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1053\/j.gastro.2016.11.004","article-title":"No Difference Between Latiglutenase and Placebo in Reducing Villous Atrophy or Improving Symptoms in Patients With Symptomatic Celiac Disease","volume":"152","author":"Murray","year":"2017","journal-title":"Gastroenterology"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1053\/j.gastro.2014.02.031","article-title":"Glutenase ALV003 Attenuates Gluten-Induced Mucosal Injury in Patients With Celiac Disease","volume":"146","author":"Kaukinen","year":"2014","journal-title":"Gastroenterology"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1053\/j.gastro.2022.07.071","article-title":"Latiglutenase Protects the Mucosa and Attenuates Symptom Severity in Patients With Celiac Disease Exposed to a Gluten Challenge","volume":"163","author":"Murray","year":"2022","journal-title":"Gastroenterology"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1007\/s10620-016-4426-5","article-title":"AGY, a Novel Egg Yolk-Derived Anti-gliadin Antibody, Is Safe for Patients with Celiac Disease","volume":"62","author":"Sample","year":"2016","journal-title":"Dig. Dis. Sci."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"441843","DOI":"10.3389\/fped.2019.00193","article-title":"Evolving therapy for celiac disease","volume":"7","author":"Yoosuf","year":"2019","journal-title":"Front. Pediatr."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1111\/j.1365-2036.2007.03413.x","article-title":"The safety, tolerance, pharmacokinetic and pharmacodynamic effects of single doses of AT-1001 in coeliac disease subjects: A proof of concept study","volume":"26","author":"Paterson","year":"2007","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"101782","DOI":"10.1016\/j.clinre.2021.101782","article-title":"Larazotide acetate for treatment of celiac disease: A systematic review and meta-analysis of randomized controlled trials","volume":"46","author":"Hoilat","year":"2022","journal-title":"Clin. Res. Hepatol. Gastroenterol."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.peptides.2012.02.015","article-title":"Larazotide acetate regulates epithelial tight junctions in vitro and in vivo","volume":"35","author":"Gopalakrishnan","year":"2012","journal-title":"Peptides"},{"key":"ref_106","doi-asserted-by":"crossref","unstructured":"Valvano, M., Fabiani, S., Monaco, S., Calabr\u00f2, M., Mancusi, A., Frassino, S., Rolandi, C., Mosca, M., Faenza, S., and Sgamma, E. (2023). Old and New Adjunctive Therapies in Celiac Disease and Refractory Celiac Disease: A Review. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms241612800"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1056\/NEJMoa2032441","article-title":"A Randomized Trial of a Transglutaminase 2 Inhibitor for Celiac Disease","volume":"385","author":"Schuppan","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"6565","DOI":"10.1016\/j.bmc.2007.07.001","article-title":"Cyclic and dimeric gluten peptide analogues inhibiting DQ2-mediated antigen presentation in celiac disease","volume":"15","author":"Xia","year":"2007","journal-title":"Bioorg. Med. Chem."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/j.molimm.2009.10.036","article-title":"Design, synthesis and evaluation of high-affinity binders for the celiac disease associated HLA-DQ2 molecule","volume":"47","author":"Kapoerchan","year":"2010","journal-title":"Mol. Immunol."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/S2468-1253(19)30264-X","article-title":"Safety and efficacy of AMG 714 in adults with coeliac disease exposed to gluten challenge: A phase 2a, randomised, double-blind, placebo-controlled study","volume":"4","author":"Scheinin","year":"2019","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.ebiom.2017.11.018","article-title":"Epitope-Specific Immunotherapy Targeting CD4-Positive T Cells in Celiac Disease: Safety, Pharmacokinetics, and Effects on Intestinal Histology and Plasma Cytokines with Escalating Dose Regimens of Nexvax2 in a Randomized, Double-Blind, Placebo-Controlled Phase 1 Study","volume":"26","author":"Daveson","year":"2017","journal-title":"EBioMedicine"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S2468-1253(17)30110-3","article-title":"Epitope-specific immunotherapy targeting CD4-positive T cells in coeliac disease: Two randomised, double-blind, placebo-controlled phase 1 studies","volume":"2","author":"Goel","year":"2017","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1007\/s10620-011-1906-5","article-title":"Safety, tolerability, and activity of ALV003: Results from two phase 1 single, escalating-dose clinical trials","volume":"57","author":"Siegel","year":"2011","journal-title":"Dig. Dis. Sci."},{"key":"ref_114","doi-asserted-by":"crossref","unstructured":"B\u00fcchold, C., Hils, M., Gerlach, U., Weber, J., Pelzer, C., Heil, A., Aeschlimann, D., and Pasternack, R. (2022). Features of ZED1227: The First-In-Class Tissue Transglutaminase Inhibitor Undergoing Clinical Evaluation for the Treatment of Celiac Disease. Cells, 11.","DOI":"10.3390\/cells11101667"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/mi.2010.44","article-title":"Single-chain recombinant HLA-DQ2.5\/peptide molecules block \u03b12-gliadin-specific pathogenic CD4+ T-cell proliferation and attenuate production of inflammatory cytokines: A potential therapy for celiac disease","volume":"4","author":"Huan","year":"2011","journal-title":"Mucosal Immunol."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1111\/apt.15435","article-title":"Randomised clinical trial: A placebo-controlled study of subcutaneous or intradermal NEXVAX2, an investigational immunomodulatory peptide therapy for coeliac disease","volume":"50","author":"Truitt","year":"2019","journal-title":"Aliment. Pharmacol. Ther."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/20\/15482\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T21:10:21Z","timestamp":1760130621000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/20\/15482"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,23]]},"references-count":116,"journal-issue":{"issue":"20","published-online":{"date-parts":[[2023,10]]}},"alternative-id":["ijms242015482"],"URL":"https:\/\/doi.org\/10.3390\/ijms242015482","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,23]]}}}